Mylan Specialty L.P.
Records under this name other than the patents Mylan Specialty L.P. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,586,010 | Automatic injector with needle cover Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,870,827 | Automatic injector Term ended Term ended May 25, 2026 · USPTO record | Term ended | Term ended May 25, 2026 | USPTO record |
| US 8,690,836 | Auto-injector apparatus Lapsed on the fee record Ended Apr 8, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 8, 2026 | USPTO record |
| US 8,309,061 | Formulations and Methods for Treating Rhinosinusitis Term ended Ended no later than Nov 17, 2025 · Medium confidence | Term ended | Ended no later than Nov 17, 2025 | Medium confidence |
| US 8,048,035 | Automatic injector with needle cover Term ended Term ended Oct 20, 2025 · USPTO record | Term ended | Term ended Oct 20, 2025 | USPTO record |
| US 7,794,432 | Automatic injector with kickback attenuation Term ended Term ended Oct 11, 2025 · USPTO record | Term ended | Term ended Oct 11, 2025 | USPTO record |
| US 7,449,012 | Automatic injector Term ended Term ended Sep 11, 2025 · USPTO record | Term ended | Term ended Sep 11, 2025 | USPTO record |
| US 8,084,461 | Albuterol and Ipratropium Inhalation Solution, System, Kit and Method for Relieving Symptoms of Chronic Obstructive Pulmonary Disease Term ended Term ended May 20, 2025 · Medium confidence | Term ended | Term ended May 20, 2025 | Medium confidence |
| US 7,811,606 | Nasal Pharmaceutical Formulations and Methods of Using the Same Term ended Ended no later than May 11, 2025 · Medium confidence | Term ended | Ended no later than May 11, 2025 | Medium confidence |
| US 9,808,471 | Nasal pharmaceutical formulations and methods of using the same Term ended Ended no later than Feb 3, 2025 · Medium confidence | Term ended | Ended no later than Feb 3, 2025 | Medium confidence |